Document 1191
 DOCN  M9591191
 TI    [Application of T-subgroup cells assay in the immunology of
       oral-maxillofacial cancer]
 DT    9509
 AU    Lu C; Yin D; Cao D; School of stomatology, Shanghai Second Medical
       University.
 SO    Chung Hua Kou Chiang Hsueh Tsa Chih. 1995 Jan;30(1):29-31, 64. Unique
       Identifier : AIDSLINE MED/95309080
 AB    We report on T-subgroup cells in 70 cases of oral-maxillofacial cancer
       determined by T-monoclone antibody-OKT system. The results are as
       follows: CD3, CD4/CD8 value of cancer patients was decreased
       significantly, compared with that of health or oral benign tumor
       patients. CD8 was significantly increased (P < 0.001); however, CD8 was
       decreased and CD4/CD8 ratio was increased after operation. 20 cases
       underwent the dynamic testing, determined in 1 week, 1 and 3 month. The
       results are as follows: CD3, CD4, CD4/CD8 values were increased
       gradually and CD8 was decreased gradually in 17 cases of curative
       patients, but CD4, CD4/CD8, values were decreased and CD8 was increased
       significantly in 3 cases of metastased patients. Our conclusion is that
       determination of T-subgroup cells is of reference value for monitoring
       and treating cancer patients.
 DE    Adenocarcinoma/IMMUNOLOGY  Adult  Carcinoma, Squamous Cell/IMMUNOLOGY
       CD4-CD8 Ratio  English Abstract  Facial Neoplasms/*IMMUNOLOGY  Female
       Human  Male  Middle Age  Mouth Neoplasms/*IMMUNOLOGY  T-Lymphocyte
       Subsets/*IMMUNOLOGY  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).